Browsing by Author Gelber, RD

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2008Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trialsCoates, Alan; Clarke, M; Darby, S; Davies, C; Gelber, RD; Godwin, J; Goldhirsch, Aron (Prof); Gray, R; Peto, R; Pritchard, K I; Wood, W; School of Public Health: Public HealthAdjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials, The Lancet, vol.371, N/A, 2008,pp 29-40
2011Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trialCoates, Alan; Aldridge, Julie; Bernhard, Jurg; Cardoso, Fatima; Gelber, RD; Goldhirsch, Aron (Prof); Harvey, V; Pagani, O.; Phillips, Kelly-Anne; Price, K N; Ribi, Karin; Sun, Zhuoxin; Thompson, Alastair; Thurlimann, B.; School of Public Health: Public HealthCognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial, Breast Cancer Research and Treatment, vol.126, 1, 2011,pp 221-226
2009The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.Coates, Alan; Aebi, S; Basser, R; Cinieri, S.; Colleoni, Marco; et al, various; Gelber, RD; Green, M; Martinelli, G; Peccatori, F.; Sun, Zhuoxin; School of Public Health: Public HealthThe effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up., Annals of Oncology, vol.20, 8,pp 1344-1351
2011Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancerCoates, Alan; Braun, D; Castiglione-Gertsch, M; Collins, John; Crivellari, Diana; et al, various; Gelber, RD; Karlsson, Per; Price, K. N.; Rabaglio, Manuela; Sun, Zhuoxin; School of Public Health: Public HealthLong-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer, Annals of Oncology, vol.22, 10, 2011,pp 2216-2226
2009Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century.Coates, Alan; Castiglione-Gertsch, Monica; Collins, John; et al, various; Fey, Martin F.; Gelber, RD; Holmberg, Stig B.; Lindtner, Jurij; Pagani, O.; Price, K. N.; Thurlimann, Beat; School of Public Health: Public HealthPatterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century., Breast Cancer Research and Treatment, vol.117, 2,pp 319-324
2013Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013Coates, Alan; Gelber, RD; Goldhirsch, A; Piccart-Gebhart, Martine J (Prof); Senn, H.-J.; Thurlimann, B.; Winer, EP; School of Public Health: Public HealthPersonalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013, Annals of Oncology, vol.24, 9, 2013,pp 2206-2223